XML 52 R37.htm IDEA: XBRL DOCUMENT v3.20.4
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2020
Tabular disclosure of stock option grants under the Plan

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Grantee Type

    

# of
Options
Granted

    

Issued and
Outstanding

    

Vesting
Period

    

Weighted
Average
Exercise
Price

    

Weighted Average
Grant Date
Fair Value
(Per Option)

​

​

​

​

​

​

​

​

​

​

​

​

​

Director Group

​

150,000

​

100,000

​

5 years

​

$

9.98

​

$

4.36

Employee Group

​

4,662,630

​

3,014,931

​

3-5 years

​

$

5.60

​

$

3.08

Total

​

​

​

3,114,931

​

​

​

​

​

​

​

​

Schedule of fair value assumptions of stock option grants

​

​

​

​

​

​

​

​

​

​

2020

    

2019

​

2018

Weighted average expected life

​

6.0 years

​

6.3 years

​

6.5 years

Risk-free interest rates

​

0.39% to 0.47%

​

1.45% to 2.58%

​

2.28% to 3.00%

Expected volatility

​

41.0% to 42.5%

​

32.5% to 37.9%

​

36.7% to 39.9%

Expected dividend yield

​

0.00%

​

0.00%

​

0.00%

Schedule of summary of option activity under the Plan and changes during the period

​

​

​

​

​

​

​

​

​

​

​

​

​

    

Shares

    

Weighted
Average
Exercise
Price

    

Weighted
Average
Remaining
Contractual
Terms (Years)

    

Aggregate
Intrinsic
Value (in
millions)

Outstanding as of January 1, 2019

​

2,066,529

​

$

10.23

​

8.5

​

$

—

Granted

​

631,136

​

​

3.20

​

​

​

​

​

Forfeited or expired

​

(388,741)

​

​

9.73

​

​

​

​

​

Outstanding as of December 31, 2019

​

2,308,924

​

​

8.39

​

8.0

​

​

0.2

Granted

​

2,029,900

​

​

1.75

​

​

​

​

​

Forfeited or expired

​

(1,223,893)

​

​

2.96

​

​

​

​

​

Outstanding as of December 31, 2020

​

3,114,931

​

$

6.19

​

7.9

​

$

5.9

​

​

​

​

​

​

​

​

​

​

​

Exercisable as of December 31, 2020

​

1,139,811

​

​

9.26

​

6.7

​

​

0.4

Vested and expected to vest as of December 31, 2020

​

3,114,931

​

$

6.19

​

7.9

​

$

5.9

Summary of restricted stock unit grants under the Plan

​

​

​

​

​

​

​

​

​

​

​

Grantee Type

    

# of
Restricted Stock
Units Granted

    

Issued and Outstanding

    

Vesting
Period

    

Weighted Average Grant Date Fair Value (Per Unit)

​

​

​

​

​

​

​

​

​

​

Director Group

​

893,996

​

340,415

​

1-2 years

​

$

2.75

Employee Group

​

1,568,655

​

254,386

​

5 years

​

$

10.59

Total

​

​

​

594,801

​

​

​

​

​

Summary of restricted stock awards activity under the Plan

​

​

​

​

​

​

​

​

    

Units

    

Weighted
Average Grant
Date Fair Value
(Per Unit)

​

​

​

​

​

​

Non-vested as of January 1, 2019

​

841,361

​

$

10.44

Granted

​

753,986

​

​

2.45

Vested

​

(187,956)

​

​

10.35

Forfeited

​

(226,509)

​

​

10.16

Non-vested as of December 31, 2019

​

1,180,882

​

​

5.44

Granted

​

108,498

​

​

2.77

Vested

​

(600,900)

​

​

4.05

Forfeited

​

(93,679)

​

​

9.42

Non-vested as of December 31, 2020

​

594,801

​

$

5.72

Summary of performance stock unit grants under the Plan

​

​

​

​

​

​

​

​

    

Units

    

Weighted
Average Grant
Date Fair
Value
(Per Unit)

​

​

​

​

​

​

Non-vested as of January 1, 2020

​

—

​

$

—

Granted

​

2,471,500

​

​

1.14

Vested

​

—

​

​

—

Forfeited

​

(755,400)

​

​

0.59

Non-vested as of December 31, 2020

​

1,716,100

​

$

1.38

Performance Stock Units  
Schedule of fair value assumptions of stock option grants

​

​

​

​

​

​

​

​

​

As of December 31, 2020

​

​

Liability-classified

​

​

Equity-classified

Term

    

2.3 to 2.6 years

​

​

1.9 to 3.0 years

Risk-free interest rate

​

0.14% to 0.15%

​

​

0.13% to 0.21%

Expected volatility

​

92.3% to 96.5%

​

​

86.1% to 102.2%

Expected dividend yield

​

0.00%

​

​

0.00%